SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001019056-13-000423
Filing Date
2013-03-22
Accepted
2013-03-22 15:35:01
Documents
1
Period of Report
2012-08-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT reinisch_3.html 3  
1 OWNERSHIP DOCUMENT reinisch_3.xml 3 2148
  Complete submission text file 0001019056-13-000423.txt   3533
Mailing Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122 858-452-6600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4 BARRETT WOODS BALLWIN MO 63021
Business Address
Reinisch Richard (Reporting) CIK: 0001572691 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-24274 | Film No.: 13711141